Ozonation of ciprofloxacin in water: HRMS identification of reaction products and pathways

Environmental Science and Technology

Volumn 42, Issue 13, 2008, Pages 4889-4895

  Dewitte, Bavo ^a   Dewulf, Jo ^a   Demeestere, Kristof ^a   Van De Vyvere, Vincent ^a   De Wispelaere, Patrick ^a   Van Langenhove, Herman ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ADDITION REACTIONS; ANTIBIOTICS; BUBBLE COLUMNS; HEALTH; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIGH PRESSURE LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; OZONE; OZONE WATER TREATMENT; OZONIZATION; REACTION KINETICS; SOLUTIONS; SULFATE MINERALS; REACTION PRODUCTS; SCAVENGING;

ANTHRANILIC ACIDS; AQUEOUS SOLUTIONS; CIPROFLOXACIN (CIPRO); DEGRADATION PRODUCTS; HIGH RESOLUTION MASS SPECTROMETRY (HRMS); HPLC UV; OZONATION; QUINOLONE; REACTION PATHWAYS; REACTION PRODUCTS;

DEGRADATION;

ANTHRANILIC ACID DERIVATIVE; CARBOXYLIC ACID DERIVATIVE; CIPROFLOXACIN; HYDROXYL RADICAL; ISATIN; PIPERAZINE DERIVATIVE; QUINOLONE; SCAVENGER; TERT BUTYL ALCOHOL;

ANTIBIOTICS; AQUEOUS SOLUTION; BACTERIUM; DEGRADATION; IDENTIFICATION METHOD; MASS SPECTROMETRY; OZONE; WATER POLLUTION;

ANTIBIOTIC RESISTANCE; AQUEOUS SOLUTION; ARTICLE; BUBBLE COLUMN REACTOR; DEGRADATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NONHUMAN; OZONATION; PH; ULTRAVIOLET RADIATION; WATER CONTAMINATION;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CIPROFLOXACIN; FRESH WATER; MASS SPECTROMETRY; MOLECULAR STRUCTURE; OZONE; WATER POLLUTANTS, CHEMICAL;

BACTERIA (MICROORGANISMS);

ANTHRANILIC ACID; ANTI-BACTERIAL ACTIVITY; BACTERIAL RESISTANCE; CARBOXYLIC GROUP; CIPROFLOXACIN; CONTAMINATED WATER; DEGRADATION PRODUCTS; HIGH RESOLUTION MASS SPECTROMETRY; HPLC-UV; HYDROXYL RADICALS; KETO GROUPS; QUINOLONE CORES; QUINOLONES; REACTION PATHWAYS; T-BUTANOL;

EID: 46849088123     PISSN: 0013936X     EISSN: None     Source Type: Journal    
DOI: 10.1021/es8000689     Document Type: Article

References (29)

1. Huber, M. M.; Göbel, A.; Joss, A.; Hermann, N.; Löffler, D.; Mcardell, C. S.; Ried, A.; Siegrist, H.; Ternes, T. A.; Von Gunten, U. Oxidation of pharmaceuticals during ozonation of municipal wastewater effluents: a pilot study. Environ. Sci. Technol. 2005, 39, 4290-4299.
2. Wetzstein, H. G.; Stadler, M.; Tichy, H. V.; Dalhoff, A.; Karl, W. Degradation of ciprofloxacin by basidiomycetes and identification of metabolites generated by the brown rot fungus Gloeophyllum striatum. Appl. Environ. Microb. 1999, 65, 1556-1563.
3. Tesar, T.; Foltán, V.; Langsadl, L.; Baňasová, K. Utilisation of antibiotics within Europe and the trends of consumption in the Slovak Republic. Acta Fac. Pharm. Univ. Comenianae 2004, 51, 207-216.
4. Hartmann, A.; Golet, E. M.; Gartiser, S.; Alder, A. C.; Koller, T.; Widmer, R. M. Primary DNA damage but not mutagenicity correlates with ciprofloxacin concentrations in German hospital wastewaters. Arch. Environ. Con. Tox. 1999, 36, 115-119.
5. Batt, A. L.; Bruce, I. B.; Aga, D. S. Evaluating the vulnerability of surface waters to antibiotic contamination from varying wastewater treatment plant discharges. Environ. Pollut. 2006, 142, 295-302.
6. Larsson, D. G.; De Pedro, C.; Paxeus, N. Effluent from drug manufacturers contains extremely high levels of pharmaceuticals. J. Hazard. Mater. 2007, 148, 751-755.
7. Kümmerer, K.; Al-Ahmad, A.; Mersch-Sundermann, V. Biodegradability of some antibiotics, elimination of the genotoxicity and affection of wastewater bacteria in a simple test. Chemosphere 2000, 40, 701-710.
8. Ikehata, K.; Naghashkar, N. J.; Gamal El-Din, M. Degradation of aqueous pharmaceuticals by ozonation and advanced oxidation processes: a review. Ozone-Sci. Eng. 2006, 28, 353-414.
9. 2 materials - determination of intermediates and reaction pathways. Water Res. 2004, 38, 955-964.
10. 2 treatment of antiepileptic drug carbamazepine. Chemosphere 2004, 54, 497-505.
11. 2 processes. Chemosphere 2003, 50, 85-95.
12. Ötker, M.; Balcioǧlu, I. A. Adsorption and degradation of enrofloxacin, a veterinary antibiotic on natural zeolite. J. Hazard Mater. 2005, 122, 251-258.
13. Dodd, M. C.; Buffle, M. O.; Von Gunten, U. Oxidation of antibacterial molecules by aqueous ozone: moiety-specific reaction kinetics and application to ozone-based wastewater treatment. Environ. Sci. Technol. 2006, 40, 1969-1977.
14. 2 photocatalysis of fluoroquinolone antibacterial agents. Environ. Sci. Technol. 2007, 41, 4720-4727.
15. Siminiceanu, I.; Bobu, M. M. A comparative study of the ciprofloxacin degradation in water by several advanced oxidation processes. Rev. Chim.-Bucharest 2006, 57, 1082-1085.
16. De Witte, B.; Dewulf, J.; Demeestere, K.; Van Langenhove, H. Ozonation and advanced oxidation by the peroxone process of ciprofloxacin in water. J. Hazard Mater. 2008, DOI:10.1016/j.jhazmat.2008.04.021.
17. Andreozzi, R.; Campanella, L.; Fraysse, B.; Garric, J.; Gonnella, A.; Lo Giudice, R.; Marotta, R.; Pinto, G.; Pollio, A. Effects of advanced oxidation processes (AOPs) on the toxicity of a mixture of pharmaceuticals. Water Sci. Technol. 2004, 50, 23-28.
18. Atlantis Columns Applications Notebook; Waters, 2004.
19. Karl, W.; Schneider, J.; Wetzstein, H. G. Outlines of an exploding network of metabolites generated from the fluoroquinolone enrofloxacin by the brown rot fungus Gloeophyllum striatum. Appl. Microb. Biotechnol. 2006, 71, 101-113.
20. Yamamoto, Y.; Niki, E.; Shiokawa, H.; Kamiya, Y. Ozonation of organic compounds.2. Ozonation of phenol in water. J. Org. Chem. 1979, 44, 2137-2142.
21. Beltran, F. J. Ozone Reaction Kinetics for Water and Wastewater Systems; CRC Press LLC: Boca Raton, FL, 2004.
22. De Witte, B.; Dewulf, J.; Demeestere, K.; De Ruyck, M.; Van Langenhove, H. Critical points in the analysis of ciprofloxacin by high-performance liquid chromatography. J. Chromatogr., A 2007, 1140, 126-130.
23. Bezbarua, B. K.; Reckhow, D. A. Modification of the standard neutral ozone decomposition model. Ozone-Sci. Eng. 2003, 26, 345-357.
24. Andreozzi, R.; Caprio, V.; Insola, A.; Marotta, R. Advanced oxidation processes (AOP) for water purification and recovery. Catal. Today 1999, 53, 51-59.
25. Chu, D. T. W.; Fernandes, P. B. Structure-activity relationships of the fluoroquinolones. Antimicrob. Agents Chemother. 1989, 33, 131-135.
26. Wetzstein, H. G.; Schmeer, N.; Karl, W. Degradation of the fluoroquinolone enrofloxacin by the brown rot fungus Gloeophyllum striatum: Identification of metabolites. Appl. Environ. Microb. 1997, 63, 4272-4281.
27. Shen, L. L.; Mitscher, L. A.; Sharma, P. N.; O'Donnel, T. J.; Chu, D. W. T.; Cooper, C. S.; Rosen, T.; Pernet, A. G. Mechanism of inhibition of DNA gyrase by quinolone antibacterials: a cooperative drug-DNA binding model. Biochemistry 1989, 28, 3886-3894.
28. Bielecka-Grzela, S.; Klimowicz, A. Penetration of ciprofloxacin and its desethylenemetabolite into skin in humans after a single oral dose of the parent drug assessed by cutaneous microdialysis. J. Clin. Pharm. Ther. 2005, 30, 383-390.
29. Zeiler, H.-J.; Petersen, U.; Gau, W.; Ploschke, H. J. Antibacterial activity of the metabolites of ciprofloxacin and its significance in the bioassay. Drug. Res. 1987, 37, 131-134.